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Abstract
Background: Salmonella meningitis remains a threat to children below two years of age in both developing and
developed countries. However, information on such infections has not been well characterized. We analyzed data
related to twelve years of experience in order to clarify the comprehensive features of Salmonella meningitis in our
patients, including admission characteristics, acute complications, and long-term outcome.
Methods: The records of patients with spontaneous Salmonella meningitis from 1982 to 1994 were retrospectively
reviewed. The long-term outcome was prospectively determined for survivors at school age by the developmental
milestones reported by their parents and detailed neurological evaluation along with intelligence, hearing, visual,
speech and language assessments.
Results: Of the twenty-four patients, seizures were noted in fifteen (63%) before admission and thirteen (54%)
during hospitalization. Acute complications mainly included hydrocephalus (50%), subdural collection (42%),
cerebral infarction (33%), ventriculitis (25%), empyema (13%), intracranial abscess (8%), and cranial nerve palsy (8%).
Three patients (13%) died during the acute phase of Salmonella meningitis. The twenty-one survivors, on whom
we followed up at school age, have sequelae consisting of language disorder (52%), motor disability (48%),
intelligence quotient < 80 (43%), epilepsy (33%), sensorineural hearing loss (17%), visual deficits (10%), abducens
nerve palsy (5%), microcephaly (5%), and hydrocephalus (5%). Overall, good outcome was noted in six (28.6%) of
twenty-one survivors, mild sequelae in three (14.2%), moderate in six (28.6%), and severe in six (28.6%).
Conclusion: Salmonella meningitis in neonates and infants had a wide spectrum of morbidity and acute
complications, leading to a complicated hospital course and subsequently a high prevalence of permanent adverse
outcome. Thus, early recognition of acute complications of Salmonella meningitis and a follow-up plan for early
developmental assessment of survivors are vital.
Background
Salmonella strains are an important pathogen of child-
hood bacterial meningitis in many developing countries,
accounting for 5-13% of acute bacterial meningitis in
young children in the 1980s-2000s [1-4]. In developed
countries, Salmonella meningitis is a rare form (1% or
less) of acute bacterial meningitis, but such infections are
serious and thus still a threat to children below the age of
two [5,6]. In 1907, Ghon reported the first case of Salmo-
nella meningitis [7]. The previous reports suggested that
Salmonella meningitis was associated with a very high
prevalence (50-90%) of morbidity, presenting variable
complications, and a high mortality rate of up to 50-70%
[8-15]. However, comprehensive information regarding
Salmonella meningitis, including clinical features, com-
plications, and long-term sequelae among survivors has
not been well characterized. To clarify these systemic fea-
tures, particularly long-term outcomes of Salmonella
meningitis occurring in neonates and infants primarily
admitted to Changhua Christian Hospital from 1982 to
1994, the clinical characteristics of the disease present at
hospital admission were retrospectively reviewed, and a
follow-up assessment of patients at school age was pro-
spectively undertaken.
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Changhua Christian Hospital is a teaching hospital in
central Taiwan that serves as a referral center as well
as a primary care facility. From 1982 to 1994, we col-
lected one to three cases with Salmonella meningitis
annually for a total of twenty six patients. Twenty four
of them received first aid and all medical care in our
hospital, and the other two were referred to us after
partial antibiotic treatment by local medical care. After
1994, only a few cases with Salmonella meningitis
were collected in our hospital due to public health
improvements in Taiwan, and they were referred by
local medical care. Since the group of referred cases
with Salmonella meningitis was small and treated with
varied durations of antibiotics before admission, this
group was excluded from our study. The medical
records of all patients primarily admitted to our hospi-
tal from 1982 to 1994 with spontaneous Salmonella
meningitis were reviewed. They fulfilled the entry cri-
teria for diagnosis by the presence of Salmonella spe-
cies in cerebrospinal fluid (CSF) culture, which further
supported infection based on pleocytosis (> 30/mm
3)
with predominant neutrophilia and hypoglycorrhachia.
Records were examined for initial clinical presenta-
tions, demographic features, laboratory data, acute
complications at hospitalization, and antibiotic ther-
apy. In this study, the modified Grady coma scale was
used to measure the level of consciousness, classing
children on a scale of I to V along a scale of lethargy
or irritability (grade I), stupor (grade II), deep stupor
(grade III), coma with abnormal posturing (grade IV),
and coma without any respon s e( g r a d eV )[ 1 6 ] .F o l -
low-up on surviving cases was performed at pediatric
neurology outpatient clinics after discharge. This study
was conducted with the approval of the Ethical
Research Committee of Changhua Christian Hospital.
W r i t t e ni n f o r m e dc o n s e n t sw e r eo b t a i n e df r o mt h e
participants and their parents after full oral and writ-
ten explanation of the evaluation procedures, and the
purpose of the study.
The survivors and/or their parents were asked to com-
plete a questionnaire detailing developmental problems
and presence of a seizure disorder. Developmental delay
was defined as a child not reaching developmental mile-
stones at the expected times, including motor develop-
ment, hearing, speech and language. In addition, a
pediatric neurologist determined the presence of motor
disabilities and sequelae in survivors based on neurologi-
cal examinations. Motor disability was defined as
reduced ability to perform normal human motor func-
tions, such as standing and walking. Hearing function
was assessed with conventional behavioral pure-tone
audiometry. General intelligence was measured using
the Wechsler Intelligence Scale for Children-Revised
(WISC-R) [17]. Language ability was assessed with a lan-
guage assessment test as previously described [18]. Cere-
bral background activity and epileptiform discharge were
detected by electroencephalography (EEG). Cranial com-
puted tomography (CT) scan was also performed to
document brain tissue changes following Salmonella
meningitis.
In addition to considering individual assessment
results and events of Salmonella meningitis during hos-
pitalization, the overall outcome was classified according
to previous reports with a few modifications [19]. These
were as follows: (1) death: death was associated with
Salmonella meningitis; (2) severe adverse outcome:
severe cerebral palsy (vegetative state and/or tetrapar-
esis, tetraplegia), profound or severe intellectual impair-
ment (intelligence quotient (IQ) score < 55), profound
or severe delayed language development (≥ 3s t a n d a r d
deviations (SD) below the mean on the full score of the
preschool language scale), intractable epilepsy, sensori-
neural hearing loss ≥ 60 dB, and/or bilateral cranial
nerve palsy or deficits; (3) moderate adverse outcome:
moderate to mild cerebral palsy (hemiparesis or para-
paresis), moderate intellectual impairment (IQ score
between 55 and 69), moderate delayed language devel-
opment (< 3 SD and ≥ 2 SD below the mean), sensori-
neural hearing loss (59 to 40 dB), one side of cranial
nerve palsy or deficits, and/or epilepsy; (4) mild adverse
outcome: minimal neurological impairment (generalized
hyperreflexia and/or clumsiness), mild intellectual
impairment (IQ score between 70 and 80), mild delayed
language development (< 2 SD and ≥ 1.5 SD below the
mean), and/or hydrocephalus without complications;
and (5) good outcome: no motor disability, no intellec-
tual impairment (IQ score > 80), and normal language
development (< 1.5 SD from the mean).
Data is expressed as mean ± SD or median (range).
Clinical features at the time of admission and acute
complications of Salmonella meningitis were evaluated
to find the relevant predictors associated with death,
severe adverse outcome, and moderate adverse outcome
using the 2-tailed Fisher’s exact test (SPSS for Windows,
version 15, SPSS Inc, Chicago, IL). P value < 0.05 was
considered significant.
Results
Clinical Characteristics and Acute Complications of
Salmonella Meningitis
We collected a total of twenty-four patients (six neo-
nates and eighteen infants) with Salmonella meningitis,
who had not received any treatment for the illness
before coming to our hospital. All children with growth
of Salmonella from CSF also fit the other criteria of the
CSF pleocytosis (> 30/mm
3) with predominant neutro-
philia and hypoglycorrhachia for meningitis. The records
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tis were fully reviewed and all survivors were completed
follow-up. Their basic data at the acute phase of Salmo-
nella meningitis is summarized in Table 1. HIV infec-
tion and other risk factors for invasive disease were
absent in our cases. They were admitted to our hospital
within three days after symptom onset. The most com-
mon agents were Salmonella enteritidis Group D1
(41.7%); others included Salmonella enteritidis Group B
(12.5%), Salmonella enteritidis Group C1 (8.3%), Salmo-
nella enteritidis Group C2 (4.2%) and Salmonella spe-
cies (33.3%). Clinical features were similar in both the
neonate and infant groups at the time of admission,
except that a bulging anterior fontanel appeared to be
more common in infants (61%) than in neonates (33%).
Seizures were noted in 15 (63%) of the twenty-four
patients before admission. Seizures occurred in thirteen
(54%) during hospitalization, and ten (77%) of those sei-
zures were not well controlled even though antiepileptic
drugs were administrated for > 48 hours. Six (25%) had
no seizures noted in the course of Salmonella meningi-
tis. The laboratory findings for the twenty-four patients
are listed in Table 2. Cerebrospinal fluid (CSF)/blood
glucose ratio < 0.5 was 83% of those cases and CSF pro-
tein levels > 200 mg/dl in 54% of the patients.
Initial antibiotics that covered Salmonella species were
used for the twenty-four patients, based on the results
of gram stains and cultures of blood and CSF. They
were treated with fourteen different antimicrobial regi-
mens, and most received chloramphenicol or ampicillin
in combination with one of the third generation cepha-
losporins (cefotaxime, moxalaxtam, ceftriaxone, and cef-
tazidime) (Table 1). In vitro sensitivities to the third
generation cephalosporins, chloramphenicol, and ampi-
cillin were 100%, 54.5%, and 45.8%, respectively. Antimi-
crobial therapy durations were 32.1 ± 12.2 days (range,
14 to 74 days). One case had acute complications,
including refractory seizures, ventriculitis, and severe
hydrocephalus, and received a ventriculoperitoneal
shunt. This patient had a relapse of Salmonella meningi-
tis with the same serotype of Salmonella 33 days after
treatment with susceptible antibiotics for 56 days.
During hospitalization, brain sonography (N = 22)
and/or CT scan (N = 18) and/or ventricular tap (N =
12) were performed to detect acute intracranial compli-
cations and to diagnose ventriculitis. Those complica-
tions included hydrocephalus (50%), subdural collection
(42%), cerebral infarction (33%), ventriculitis (25%),
empyema (13%), intracranial abscess (8%), and cranial
nerve palsy (8%) (Table 3). Of twelve cases with hydro-
cephalus, six had ventriculitis, and three with severe
non-communicating type received a ventriculoperitoneal
shunt during hospitalization. Eight patients had cerebral
infarction and most of them had one or more associated
and concomitant complications, mainly hydrocephalus
(50%), seizures (75%), subdural effusion (40%), empyema
and brain abscess (25%). Four children were found to
have focal intracranial infection: two had subdural
empyema, one had subdual empyema plus brain abscess,
Table 1 Admission features and progress of the twenty-
four patients with Salmonella meningitis
Characteristics Cases (N = 24)
n (%)
Male: Female 15: 9
Age at onset, days* 79 ± 44.5
(range, 5 to 266)
Onset of symptoms before admission, days* 2.1 ± 0.74
(range,1 to 3)
Clinical features present between onset of
symptoms and day of diagnosis
Fever 24 (100)
Lethargy 6 (25)
Irritability 10 (42)
Poor feeding 20 (83)
Diarrhea 8 (33)
Vomiting 9 (38)
Bulging anterior fontanel 13 (54)
Nuchal rigidity 9 (38)
Seizure 15 (63)
Salmonella isolates
CSF 24 (100)
Blood 13 (59)
Stool 3 (17)
Urine 1 (6)
Antibiotics
CM 1(4)
AC, CM 2 (8)
AC, third-generation cephalosporins 6 (25)
CM, third-generation cephalosporins 4 (17)
AC, CM, third-generation cephalosporins 2 (8)
AG, third-generation cephalosporins 2 (8)
Third-generation cephalosporins 7 (29)
Duration of hospitalization, days* 32.1 ± 12.2
(range, 14 to 74)
Condition at discharge
Survival 21 (88)
No disability 8 (33)
Disability 13 (54)
Ongoing seizure 7 (29)
Focal motor weakness 10 (42)
Cranial nerve palsy 2 (8)
Death 3 (13)
Relapse 1 (4)
*Values are presented as mean ± SD with range in parentheses; n (%), case
number with percentage of the patients with positive findings in parentheses;
#Denotes CSF cultures done in 24 cases, blood cultures in 22, urine cultures in
16, and stool cultures in 18; third-generation cephalosporins: cefotaxime,
moxalaxtam, ceftriaxone, and ceftazidime; AC, Ampicllin; AG, aminoglycoside;
CM, Chloramphenicol; disability, impairment of physical ability and seizure.
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had other associated and concomitant complications
such as prolonged seizures (100%), cerebral infarction
(50%), ventriculitis (50%), and abducens nerve palsy
(25%). They all received surgical management to drain
brain abscess and empyema, and had severe neurological
disability at discharge.
Outcome of Patients with Salmonella Meningitis for
School-Age Survivors
Overall, good outcome was observed in six (28.6%) of
twenty-one survivors, mild adverse outcome in three
(14.2%), moderate in six (28.6%), and severe in six
(28.6%). Table 3 summarizes the relevant unfavorable
factors associated with outcome. There was a higher
prevalence of acute complications and decreased level of
consciousness in children who had poor outcome than
in those with mild adverse and good outcomes.
Three (13%) of the twenty-four patients with Salmo-
nella meningitis died during hospitalization. The
remaining twenty-one survivors were prospectively
f o l l o w e du pw h e nt h e yw e r ea ts c h o o la g e( m e d i a n9 . 4 ,
range 7.8 to 12.2 years) and then evaluated (Table 4).
Developmental delay occurred in fourteen (67%) cases.
Nearly half (48%) of the survivors had motor disabilities.
Among five patients who had severe disabilities, two
had spastic tetraplegia with / w i t h o u tu r i n ea n ds t o o l
incontinence, and three had spastic tetraplegia in a vege-
tative state. Among four with moderate impairment,
three had spastic hemiparesis and one had spastic para-
paresis. One patient with mild impairment showed slight
clumsiness and generalized hyperreflexia. In addition,
ataxia was noticed in two patients with hemiparesis, and
involuntary movement was noticed in three patients
with tetraplegia.
Seven (33%) cases of the twenty-one survivors devel-
oped epilepsy. Five had refractory epilepsy that developed
at the time of their acute illness, and the other two devel-
oped epilepsy post Salmonella meningitis at two and four
years. All seven cases had focal or multifocal epileptiform
discharges on EEG recordings. In addition, one survivor
who did not display clinical symptoms of seizure had
abnormal focal epileptiform discharges.
In sixteen (76%) of twenty-one children, brain CT scans
revealed abnormal findings, suggesting old infarction and
lesions associated with acute Salmonella meningitis. Mod-
erate hydrocephalus was detected in one child, who had
generalized tendon hyperreflex and good intelligence.
Another patient who had received a ventriculoperitoneal
shunt at age six months due to severe hydrocephalus had
a normal sized ventricle.
O n e( 5 % )o ft w e n t y - o n ec h i l d r e nh a dh a dl e f ta b d u -
cens nerve palsy since Salmonella meningitis and two
(10%) had visual deficits. Sensorineural hearing impair-
ment was noticed in three (17%) of the eighteen survi-
vors tested by pure-tone audiometry. Two had severe
unilateral sensorineural loss (> 60 dB) while one had
mild unilateral sensorineural loss (40 dB). The other
three survivors could not be tested due to their severe
disabilities.
The language assessment test for school-age children
was designed to identify language comprehension and
verbal expression ability [18]. Of the twenty-one survi-
vors who completed the test, eleven (52%) were found
to have speech and language developmental delay, of
whom five had severe communication problems or
absence of speech. Thus, these five could not perform
the neuropsychological tasks on the WISC-R, and the
estimated score for each was assigned a poor perfor-
mance under -3 SD for age because of their severe intel-
lectual disabilities. The other sixteen children completed
the WISC-R. The median full-scale IQ for these 16
cases was 93.5 (range, 48 to 107). Two children had bor-
derline learning difficulty and another two had a moder-
ate learning difficulty or worse.
Table 3 summarizes the relevant predictors associated
with death and severe to moderate adverse outcomes
found by univariate analyses. The major unfavorable fac-
tors presented during Salmonella meningitis were con-
scious change, seizure during hospitalization, CSF/blood
glucose ratio < 0.5, CSF protein > 200 mg/dl, focal
intracranial infection, ventriculitis, and cerebral infarc-
tion. The features including seizure onset before admis-
sion, subdural collection, and hydrocephalus were not
significantly associated with a poor long-term outcome.
Discussion
In this study, three out of twenty-four patients with
spontaneous Salmonella meningitis died, representing a
Table 2 Analysis of peripheral leukocytes and CSF at the
time of diagnosis
Findings Cases (N = 24) n (%)
Peripheral blood data
Total WBC/μl* 12210 (1570-28900)
Segmented WBC/μl* 4760 (527-17138)
Banded WBC/μl* 389 (0-4624)
Platelet (×10
4/μl)* 32.7 (7.4-87.5)
CSF data
Total WBC/μl* 1852 (68-30600)
PMN/μl* 1490 (65-24480)
Glucose (mg/L)* 15 (0-69)
Protein (mg/dl)* 330 (40-740)
CSF/blood glucose ratio < 0.5 20 (83)
CSF protein > 200 mg/dl 13 (54)
Gram stain positive 24 (100)
* Values are presented as median (complete range); WBC, white blood cell;
PMNs, polymorphonuclear leukocytes.
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children with Salmonella meningitis
Variable Death, moderate and severe sequelae group
(N = 15) n (%)
Mild sequelae and good outcome group
(N = 9) n (%)
Level of consciousness
Lethargy or irritability at
admission*
13 (87) 3 (33)
Coma in hospital
#* 10 (67) 0 (0)
Seizures
Seizure before admission 10 (67) 5 (56)
Seizure in hospital* 12 (80) 1 (11)
Laboratory tests
CSF: blood glucose < 0.5* 15 (100) 5 (56)
CSF protein > 200 mg/dl* 11 (73) 2 (22)
Intracranial complications
Subdural collection 6 (40) 4 (44)
Intracranial focal infection* 5 (33) 0 (0)
Empyema 3 (20) 0 (0)
Brain abscess 2 (13) 0 (0)
Cerebral infarction* 8 (53) 0 (0)
Ventriculitis* 6 (40) 0 (0)
Hydrocephalus 9 (60) 3 (33)
*Denotes a significant difference between death, moderate and severe sequelae group and mild adverse and good outcome group in the univariate analysis
using Fischer’s exact test (p < 0.05);
#Denotes Grady coma scale IV and V.
Table 4 Long-term outcome associated with acute main complications for Salmonella meningitis in twenty-one survivors
Findings Survivors (N = 21)
n/total (%)*
Number of acute main complications in each particular outcome
Seizure
# Sudural
effusion
Hydro- cephalus Ventr-iculitis Em-pyema Brain
abcess
Cerebral
infarction
Development
Delayed 14/21 (67) 11 5 8 5 3 2 7
Normal 7/21 (23) 0 4 3 0 0 0 0
Motor
disability
Severe 5/21 (24) 5 2 5 5 1 2 3
Moderate 4/21 (19) 3 3 1 0 1 0 4
Mild 1/21 (5) 0 0 0 0 0 0 0
Normal 11/21 (52) 3 4 4 0 1 0 0
Hearing
Problems
3/18 (17) 2 1 3 1 1 1 0
Epilepsy 7/21 (33) 6 2 4 4 3 2 5
Microcephaly 1/21 (5) 1 0 1 1 0 1 1
Hydrocephalus 1/21 (5) 0 0 0 0 0 0 0
Visual deficit 2/21 (10) 1 2 1 0 0 0 1
CN6 palsy 1/21 (5) 0 1 1 0 0 0 0
Intelligence
IQ < 55 6/21 (29) 6 2 5 5 2 2 4
IQ 55-69 1/21 (5) 1 0 0 0 1 0 0
IQ 70-80 2/21 (10) 1 1 1 0 0 0 1
IQ > 80 12/21 (57) 3 6 5 0 0 0 2
Speech/
language
Abnormal 11/21 (52) 9 4 7 5 3 2 6
Normal 10/21 (48) 2 5 4 0 0 0 1
*Values are expressed as number of patients with each particular outcome/number of patients examined, and numbers in parentheses are percentages;
#Seizure
in hospital; CN6, Abducens nerve palsy; MR, mental retardation; IQ, intelligence quotient.
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least one complication at the acute phase of Salmonella
meningitis, leading to a complicated clinical course. At
school-age follow-up, fifteen (71%) of the twenty-one
survivors had subsequent motor disabilities, epilepsy,
language delay, and intelligence impairment (Table 4),
and most (58%) suffered from moderate to severe seque-
lae. We further revealed that death and major adverse
outcomes were highly associated with seven unfavorable
factors during Salmonella meningitis: conscious change,
seizure during hospitalization, CSF/blood glucose ratio
< 0.5, CSF protein > 200 mg/dl, focal intracranial infec-
tion, ventriculitis, and cerebral infarction (Table 3)
The incidence (71%) of mild to severe adverse long-term
outcomes in our twenty-one survivors was high, compared
with those in the previous studies [8-13,15]. One explana-
tion is that our cases demonstrated more complicated
involvement of the brain, such as cerebral infarction. On
the other hand, our children were followed up at school
age. Almost all previous studies involved follow-up of chil-
dren aged less than five years [8-13,15]. Since survivors
remain at high risk for neurologic sequelae and lifelong
impairment following meningitis [20,21], there is difficulty
in assessing those cases, particularly during the neonate
period or during the first two years of life. Our study may
thus provide a more accurate assessment for survivors,
and give an incidence of adverse long-term outcome
resulting from Salmonella meningitis.
Previous studies have demonstrated many prognostic
factors for an unfavorable outcome of bacterial meningi-
tis in children, such as Streptococcus pneumoniae
meningitis [2,22]. Since Salmonella meningitis is a rela-
tively rare form of bacterial meningitis in neonates and
infants, until now, there have been few studies that
focus on the predictive factors for long-term outcomes
[10,12]. Although our case number was not so large,
this study does allow us to assess trends in the distribu-
tion of an adverse outcome in relation to factors dis-
cernible at the acute phase of Salmonella meningitis
(Table 3). The group with major adverse outcome and
death was highly associated with seven unfavorable fac-
tors in comparison to the group with mild to no adverse
outcome in univariate analysis (p < 0.05, Fisher’s exact
test), e.g. conscious alteration, late seizures, high CSF
protein, low CSF/blood glucose ratio, cerebrovascular
involvement, and intracranial infectious complications
(Table 3). These factors are consistent with most predic-
tive factors found in other bacterial meningitis [2,22].
Treatment of Salmonella meningitis has not been well
defined. Antimicrobial agents, including chlorampheni-
col, ampicillin, and cotrimoxazole, had a low cure rate (~
40%) and a highly associated mortality (~ 45%) [23].
Third-generation cephalosporins and fluoroquinolones
had a high cure rate (> 80%) and lowered the associated
mortality (< 10%) [10,24-26]. Thus, those two antibiotics
would be regarded as the optimal antimicrobial regimens
in the treatment of Salmonella meningitis [26]. All our
patients were treated initially with antibiotics to which
their Salmonella species was susceptible, and most
received third-generation cephalosporins, combined with
chloramphenicol or ampicillin. Similar to the previous
report [10], the mortality rate in our cases declined to
about 10%, but the morbidities remained high, up to
75%. The results suggest that susceptible antibiotics for
treatment of Salmonella meningitis in children were
unsatisfactory. Adjunctive dexamethasone, therefore,
may be recommended to attenuate the effects of the
acute innate inflammatory response to bacterial invasion
within the CNS [27,28], although the benefits of steroids
in meningitis seemed controversial in developing coun-
tries [29]. In addition, the patient should be monitored in
the intensive care unit for any morbidity, such as seizure,
in order to detect its potential complication.
In the present study, there are some limitations that
merit discussion. The admission features of our patients
were retrospectively collected, and the sample size was
not large enough for a good statistical analysis. The
assessment methods were not fully validated. For
instance, a standard clinical examination was performed
to identify children with a gross motor impairment,
which might not fully assess motor function in those
with minimal deficits. Nevertheless, about a half of our
postmeningitic children followed up at school age had
neuromuscular disability, which was high in prevalence
among bacterial meningitis [30-32]. Second, the study
was limited by the lack of a sibling control group for
comparison, since the possibility that some of the cogni-
tive impairment detected might not be attributive to
Salmonella meningitis must be considered. However,
each of the tests used for neuropsychological and lan-
guage assessment had been validated for normal popula-
tions, providing assurance that the intellectual deficits
noted were the result of Salmonella meningitis. Our
children with moderate to profound MR had more risk
factors (5.2 ± 0.5) than those with normal average IQ
and mild MR (1.6 ± 1.1) (Table 3). Thus, the results
suggest that their motor disabilities and cognitive
impairment might be highly related to the severity of
their medical condition during the acute phase.
Conclusions
In summary, the present study provides more insight
into a clinical spectrum and long-term outcome in the
patients with Salmonella meningitis. Our study further
revealed that Salmonella meningitis resulted in a high
prevalence of long-term adverse outcome, being linked
with its insult of acute complications, and a broad range
of the potential neurological sequelae after meningitis
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Page 6 of 7remained with age. Early recognition of acute complica-
tions of Salmonella meningitis and a follow-up plan for
early developmental assessment of survivors are vital.
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